Dr. Lal Pathlabs Limited Declares Interim Dividend for the Financial Year 2021-2022, Payable on or Before August 28, 2021
July 30, 2021 at 03:57 am EDT
Share
Dr. Lal PathLabs Limited at its board meeting held on July 30, 2021, declared interim dividend of INR 6 per equity share (i.e. 60% on a face value of INR 10 per share) for the Financial Year 2021- 2022. The company has fixed August 22, 2021 as the record date for the purpose of payment of interim dividend. The interim dividend will be paid by the Company on or before August 28, 2021.
Dr. Lal PathLabs Limited is an India-based company that is engaged in providing diagnostic and related healthcare tests and services. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. The Companyâs subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, and Dr. Lal PathLabs Nepal Private Limited.
DR. LAL PATHLABS LIMITED 
